Shayne Heffernan

Thoughts

Longevity

Longevity has real capital behind it now, which means it also has real marketing. The useful question is no longer whether healthspan can be extended, but which interventions have evidence, which are plausible and unproven, and which are being sold well ahead of the data.

Articles in Longevity

18 November 2026

Thoughts on Thinking: Brain Essentials

Your brain runs on about 20 watts. The fastest supercomputer outruns it, but at the central published estimate the brain is about 680 times as efficient per watt as the best machine on the November 2026 Green500. It runs on four inputs most people overlook. Creatine buffers its energy, DHA builds its membranes, exercise raises its growth factors and, in older adults, enlarges the hippocampus, and low vitamin D goes with slower processing and more dementia.

17 November 2026

KXCO's FDA Ontology Is Two for Two on FDA Decisions

The FDA has decided two filings on KXCO's FDA board since the board began ranking them, and on my scorecard the board got both right. It ranked Inovio's INO-3107 first and the FDA approved it on 30 October; Inovio moved +149.1% net of the sector. It gave Summit's ivonescimab no call, and Summit announced the FDA's refusal on 15 November; Summit fell 16.5%. KXCO's record held the FDA's survival warning before the refusal was announced.

16 November 2026

The Week Ahead on Wall Street, 16 November 2026: Look for the Bounce

NVIDIA reports on Tuesday 17 November 2026, its first results since Jensen Huang resigned, and I expect the stock and the AI market to bounce. NVIDIA closed at $162.85 on 13 November 2026, 31.93% below its record, while the semiconductor index rose 8.05% on the week. The calendar leans to currencies, with the yen near 160 after briefly crossing it, and the US publishes retail sales, housing starts, jobless claims and the Fed's minutes. Follow them on the Live Trading News trading page.

15 November 2026

KXCO's FDA Ontology Ranked INO-3107 First. Its Two Published Books Beat XBI.

KXCO's FDA ontology ranked INO-3107 first before the FDA approved it on 30 October 2026; Inovio (INO) then hit $2.71 after hours from a $0.60 close. KXCO's two published research books on the ontology stood at 109.31 and 110.28 at the close of 13 November, from 100 at the close of 14 October, against 102.58 for XBI. Nine more decisions on the board fall due before 31 December, starting with molgramostim (SVRA) and deramiocel (CAPR) on 22 November.

10 November 2026

KXCO's FDA Ontology Ranks Lorundrostat First After Its 10 November Update

KXCO's FDA ontology at kxco.ai/fda was updated in full on 10 November 2026. Its first screen now ranks Mineralys's lorundrostat (MLYS) first of the FDA decisions due within 90 days: decision 22 December, potential return +86%, per the page. Mineralys's shares fell 24.5% between reads on 20 October and 10 November. The update read six quarterly reports to 30 September by hand, and on KXCO's calculation Mineralys is funded to 12 October 2029, even if it repays its $100.0m loan by 30 June 2028.

9 November 2026

Thoughts on Thinking: You Are the Data Centre

The world's data centres used about 485 terawatt-hours of electricity in 2025; the brain runs on about 20 watts. The adult male brain holds about 86 billion neurons on average, and its synapse weights at 32-bit precision take at least 400 terabytes. Against the eye's estimated output, GPU memory wins on raw throughput by millions to one, but meaning needs selection, context and consequence. At KXCO the person sits at both ends of the data, and a named person decides.

8 November 2026

Thoughts on Thinking: Brain Chemistry

Brain chemistry sets the level of thinking and of performance in everything else, and it bears on longevity: 14 risk factors that can be changed account for nearly half of dementia cases. The dangers come from outside, through plastic, PFAS, pesticides and metals, and from inside, through chronic stress and overwork. An organic diet cut a chlorpyrifos marker in urine by 60.7 per cent, and reciting the rosary slowed breathing to under six breaths a minute. The chemistry is a managed input.

3 November 2026

KXCO's FDA Ontology Ranked INO-3107 First. Inovio Hit Over 300% After Hours.

KXCO's FDA ontology ranked INO-3107, from Inovio (INO), first of the FDA decisions due in the next 90 days, from 21 October 2026 to the decision. The FDA granted accelerated approval on 30 October; the news reached the market after the close. From its $0.60 close that day, Inovio traded as high as $2.71 after hours, up 351.7%, and closed 2 November at $1.89, up 215.0%. Both published research books closed ahead of XBI. On our radar: BBP-418 (BBIO), Bezuclastinib (COGT) and Relutrigine (PRAX).

17 October 2026

Thoughts on Thinking: Physics, Biology and Thought

Thinking is not a faculty that sits on top of the body. It is the electrochemical activity of neurons, organised into rhythms whose frequencies are set by the time constants of channels, synapses and loops. Diet, light, noise, natural settings and 40 Hz drive can shift the balance, and an MIT study of essay writing found the weakest EEG connectivity in the group using a language model. The tools and the biology work on one resource: the capacity of a named person to form and defend a judgment.

15 October 2026

Thoughts on Thinking: Take an Art Break

The best way I know to keep complex work in perspective is to stop at intervals and look at something that took the same order of sustained attention under real constraints. The studies now show what that does: a museum visit restored attention where an urban walk did not, judging the beauty of an object raised abstract thinking almost 14 per cent, and artistic film raised originality even in people who felt worse for it. Five works, Leonardo to Holbein, and the non-default decision in each.

11 October 2026

Week Ahead on Wall Street: CPI, Banks and Oil

September CPI lands on Wednesday after a Fed hike and a 10-year yield at its highest since 2002. JPMorgan, Goldman and Citi open bank earnings on Tuesday, ASML and TSMC report midweek, and Saudi pipeline attacks kept Brent at $104.72 on 9 October 2026, per CNBC. The KXCO AI Sector Ontology still shows contracted demand. This week ahead sets out the calendar, the three facts that would change the call, and why dips in the AI leaders remain buying opportunities.

11 October 2026

Optogenetics: From Nobel Prize to Commercial Reality

The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics, the method that switches defined cells on and off with light. Nanoscope's MCO-010 is now under FDA review for retinitis pigmentosa, GenSight has published its PIONEER results in the NEJM, and listed companies from Paris to Shanghai hold stakes in the developers. This piece explains the science, maps the stakes and sizes the market.

5 October 2026

The FDA Calendar to April 2027: 5 Biotech Stocks From the KXCO Biotech Ontology

The KXCO Biotech Ontology's board carries 11 pending FDA filings, due by 23 April 2027. Ranked on approval standing, the top five are BridgeBio's BBP-418, Cogent's bezuclastinib, Belite Bio's tinlarebant, Novo Nordisk's CagriSema and BioMarin's vosoritide. Ranked on consensus upside, they are Cullinan, Savara, Intellia, Mineralys and Pharvaris. No name is on both lists. This report covers BridgeBio, Cogent, Mineralys, Pharvaris and Savara.

9 September 2026

The Heirloom Foods

Heirloom foods are the working memory of agriculture. Open-pollinated plants and landrace animals that families, villages and seed savers kept because they tasted better, survived drought or frost, or simply refused to disappear. This is a map of that pantry: the ancient and heritage wheats, the sourdough cultures older than commercial yeast, the vegetables that refused to modernize, and the oldest surviving livestock breeds, with an honest account of what is known and not known about health.

8 September 2026

Frequencies and Thinking

Thinking is not a metaphor sitting on top of frequency. It is frequency, organised, across four layers that are electrical, chemical, physical and biological. A companion to The Invisible Symphony that ranks frequency pollution by the quality of the human data behind it, noise first and radiofrequency third, then turns to the part you control: what education, exercise, blood pressure, hearing, sleep, diet and purpose have actually proved about cognitive longevity.

11 August 2026

How to Retire and Grow Your Own Food

A full guide to retiring onto land that feeds you. USDA puts Ozark pasture at $3,500 an acre. Eurostat puts Latvian arable at 4,825 euro a hectare, though Bulgaria and Romania bar non-EU buyers outright. Thailand will not sell a foreigner an acre at any price. Inside: what the build really costs, which crops pay the bills, how many eggs a hen gives, how to can without killing anyone, a 36 month startup sequence, and how to check every number here.

2 August 2026

Inside KXCO Meridian: A Complete Guide for Family Offices and Private Investors

Most private capital software covers one half of the work. Deal platforms stop at the commitment, and fund administration systems start there. Meridian covers both. A full walkthrough for family offices, investors, issuers and fund administrators, from the access request through data rooms, diligence and IC memos to the vehicle layer: cap table, capital calls, the distribution waterfall, bank reconciliation, management fees and consolidated reporting. Including the limits, stated plainly.

The full center on Live Trading News

Every piece listed here is published at Live Trading News, wrapped in post-quantum cryptography (ML-DSA-65, NIST FIPS 204) and anchored on Armature L1 at the moment of publication. The text cannot be altered. Re-publish it and it is re-signed and re-stamped with a new chain time, so the original and the change both stand on the record, permanently and in public.